This protein family is endemic to Kinetoplastids, might have emerged de novo and also expanded. . The family also contains Leishmaniid members lacking the signal peptide and only having an MTTPA- start sequence
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 2, no: 9 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
Related structures:
AlphaFold database: Q4QIB1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 134 | 138 | PF00656 | 0.689 |
CLV_NRD_NRD_1 | 101 | 103 | PF00675 | 0.527 |
CLV_NRD_NRD_1 | 110 | 112 | PF00675 | 0.487 |
CLV_NRD_NRD_1 | 69 | 71 | PF00675 | 0.403 |
CLV_PCSK_FUR_1 | 99 | 103 | PF00082 | 0.495 |
CLV_PCSK_KEX2_1 | 101 | 103 | PF00082 | 0.526 |
CLV_PCSK_KEX2_1 | 110 | 112 | PF00082 | 0.485 |
CLV_PCSK_SKI1_1 | 31 | 35 | PF00082 | 0.599 |
CLV_PCSK_SKI1_1 | 70 | 74 | PF00082 | 0.398 |
DEG_MDM2_SWIB_1 | 34 | 42 | PF02201 | 0.370 |
DOC_CKS1_1 | 1 | 6 | PF01111 | 0.428 |
DOC_USP7_MATH_1 | 117 | 121 | PF00917 | 0.729 |
DOC_USP7_MATH_1 | 15 | 19 | PF00917 | 0.386 |
DOC_USP7_MATH_1 | 29 | 33 | PF00917 | 0.431 |
LIG_14-3-3_CanoR_1 | 110 | 115 | PF00244 | 0.690 |
LIG_14-3-3_CterR_2 | 163 | 167 | PF00244 | 0.653 |
LIG_FHA_1 | 110 | 116 | PF00498 | 0.649 |
LIG_FHA_1 | 38 | 44 | PF00498 | 0.278 |
LIG_FHA_1 | 90 | 96 | PF00498 | 0.648 |
LIG_FHA_2 | 138 | 144 | PF00498 | 0.630 |
LIG_FHA_2 | 8 | 14 | PF00498 | 0.407 |
LIG_LIR_Gen_1 | 144 | 155 | PF02991 | 0.614 |
LIG_LIR_Gen_1 | 18 | 29 | PF02991 | 0.411 |
LIG_LIR_Nem_3 | 144 | 150 | PF02991 | 0.640 |
LIG_LIR_Nem_3 | 18 | 24 | PF02991 | 0.418 |
LIG_LIR_Nem_3 | 36 | 42 | PF02991 | 0.329 |
LIG_LIR_Nem_3 | 82 | 88 | PF02991 | 0.647 |
LIG_Pex14_2 | 34 | 38 | PF04695 | 0.405 |
LIG_PTB_Apo_2 | 80 | 87 | PF02174 | 0.590 |
LIG_SH2_CRK | 21 | 25 | PF00017 | 0.401 |
LIG_SH2_CRK | 39 | 43 | PF00017 | 0.220 |
LIG_SH2_CRK | 53 | 57 | PF00017 | 0.264 |
LIG_SH2_PTP2 | 147 | 150 | PF00017 | 0.627 |
LIG_SH2_STAT3 | 66 | 69 | PF00017 | 0.620 |
LIG_SH2_STAT5 | 147 | 150 | PF00017 | 0.627 |
LIG_SH2_STAT5 | 39 | 42 | PF00017 | 0.407 |
LIG_SH2_STAT5 | 80 | 83 | PF00017 | 0.666 |
LIG_SH3_3 | 151 | 157 | PF00018 | 0.632 |
LIG_SH3_3 | 9 | 15 | PF00018 | 0.444 |
LIG_SUMO_SIM_anti_2 | 40 | 46 | PF11976 | 0.289 |
LIG_TYR_ITIM | 19 | 24 | PF00017 | 0.393 |
MOD_CK1_1 | 104 | 110 | PF00069 | 0.701 |
MOD_CK1_1 | 136 | 142 | PF00069 | 0.734 |
MOD_CK2_1 | 119 | 125 | PF00069 | 0.607 |
MOD_CK2_1 | 137 | 143 | PF00069 | 0.768 |
MOD_CK2_1 | 7 | 13 | PF00069 | 0.410 |
MOD_Cter_Amidation | 99 | 102 | PF01082 | 0.419 |
MOD_GlcNHglycan | 119 | 122 | PF01048 | 0.468 |
MOD_GlcNHglycan | 133 | 136 | PF01048 | 0.450 |
MOD_GSK3_1 | 100 | 107 | PF00069 | 0.711 |
MOD_GSK3_1 | 131 | 138 | PF00069 | 0.735 |
MOD_GSK3_1 | 29 | 36 | PF00069 | 0.456 |
MOD_N-GLC_1 | 105 | 110 | PF02516 | 0.437 |
MOD_NEK2_1 | 33 | 38 | PF00069 | 0.346 |
MOD_NEK2_2 | 29 | 34 | PF00069 | 0.363 |
MOD_PKA_1 | 101 | 107 | PF00069 | 0.682 |
MOD_PKA_1 | 110 | 116 | PF00069 | 0.680 |
MOD_PKA_2 | 100 | 106 | PF00069 | 0.684 |
MOD_PKA_2 | 109 | 115 | PF00069 | 0.702 |
MOD_PKA_2 | 89 | 95 | PF00069 | 0.662 |
MOD_PKB_1 | 99 | 107 | PF00069 | 0.708 |
MOD_Plk_1 | 126 | 132 | PF00069 | 0.668 |
MOD_Plk_4 | 110 | 116 | PF00069 | 0.668 |
MOD_Plk_4 | 15 | 21 | PF00069 | 0.432 |
MOD_Plk_4 | 29 | 35 | PF00069 | 0.373 |
TRG_ENDOCYTIC_2 | 147 | 150 | PF00928 | 0.627 |
TRG_ENDOCYTIC_2 | 21 | 24 | PF00928 | 0.400 |
TRG_ENDOCYTIC_2 | 39 | 42 | PF00928 | 0.288 |
TRG_ENDOCYTIC_2 | 53 | 56 | PF00928 | 0.341 |
TRG_ER_diArg_1 | 162 | 165 | PF00400 | 0.647 |
TRG_ER_diArg_1 | 99 | 102 | PF00400 | 0.691 |
TRG_NLS_MonoExtC_3 | 69 | 74 | PF00514 | 0.619 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P923 | Leptomonas seymouri | 42% | 79% |
A0A3S5H659 | Leishmania donovani | 86% | 100% |
A0A3S7WQ87 | Leishmania donovani | 29% | 100% |
A4H5C6 | Leishmania braziliensis | 36% | 77% |
A4H5C7 | Leishmania braziliensis | 59% | 75% |
A4HTK6 | Leishmania infantum | 29% | 100% |
A4HTK7 | Leishmania infantum | 85% | 100% |
E9AMD7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 34% | 93% |
E9AMD8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 74% | 100% |
Q4QIB2 | Leishmania major | 34% | 100% |